Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, and includes a Home link, indicating the record is temporarily inaccessible.SummaryDifference20%

- Check29 days agoChange DetectedThe page shows Revision: v3.7.0, replacing Revision: v3.6.6, indicating a version update. This update appears to be a page maintenance change rather than a study content modification.SummaryDifference0.1%

- Check43 days agoChange DetectedPage revision updated to v3.6.6, indicating a deployment/refresh of the study page. This reflects a maintenance or metadata update rather than a substantive change to study details or eligibility.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of Revision: v3.6.4, indicating a software version update for the site. No study details or content are altered as a result.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor update to the page's revision history. This change does not alter study data, eligibility criteria, or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.